258 related articles for article (PubMed ID: 15449150)
21. [5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT].
Koida T; Kimura M
Gan To Kagaku Ryoho; 1985 May; 12(5):1147-51. PubMed ID: 3922313
[TBL] [Abstract][Full Text] [Related]
22. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Oiwa T; Saito H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Funahashi K; Koike J; Saito N; Miki T; Matsumoto H; Ryu M; Shiokawa H; Tokuyama T; Goto T; Teramoto T
Gan To Kagaku Ryoho; 2004 Feb; 31(2):189-93. PubMed ID: 14997749
[TBL] [Abstract][Full Text] [Related]
24. Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer?
Tachikawa D; Arima S; Futami K; Iwashita A
Anticancer Res; 2000; 20(1C):595-600. PubMed ID: 10769701
[TBL] [Abstract][Full Text] [Related]
25. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
Hisamitsu K; Tsujitani S; Yamaguchi K; Fukuda K; Konishi I; Kaibara N
Anticancer Res; 2004; 24(4):2495-501. PubMed ID: 15330204
[TBL] [Abstract][Full Text] [Related]
26. Uracil-tegafur in early-stage lung cancer.
Graziano F
N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15309743
[No Abstract] [Full Text] [Related]
27. Tumor dihydropyrimidine dehydrogenase activity in advanced cervical carcinoma.
Nagai N; Shiroyama Y; Oshita T; Mukai K; Shigemasa K; Fujii T; Katsube Y; Matsubayashi S; Murakami T; Ohama K
Oncol Rep; 2002; 9(5):1033-40. PubMed ID: 12168069
[TBL] [Abstract][Full Text] [Related]
28. [Two cases of stage IV gastric cancer responding to chemotherapy with S-1 or UFT].
Nakamura Y; Yumiba T; Yamasaki Y; Momiyama T; Ito A; Akamaru Y; Sugimoto Y; Tamaoka N; Beppu N; Watanabe Y; Ohno K; Kasugai T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1463-6. PubMed ID: 17876147
[TBL] [Abstract][Full Text] [Related]
29. [Serum and tissue concentrations of UFT in patients with lung cancer].
Aota M; Nakayama S; Yokomise H; Jinno K; Daitoh N
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3046-55. PubMed ID: 3094458
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacodynamic study on the effectiveness of UFT against cancer of gastro-intestinal (GI) tract].
Seo Y; Matsuoka H; Kakeji Y; Morita M; Ohno S; Matsukuma A; Tomoda H; Furusawa M
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1775-80. PubMed ID: 8379669
[TBL] [Abstract][Full Text] [Related]
31. [Study on the preoperative adjuvant therapy of cancer--relation between serum and tumor tissue levels of UFT and OK-432 after administration, and skin reactions to Su-polysaccharide (Su-Ps)].
Kumazawa H; Ishikawa M; Rei S; Saito H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3329-35. PubMed ID: 3120645
[TBL] [Abstract][Full Text] [Related]
32. Uracil-tegafur in early-stage lung cancer.
Altundag O; Altundag K; Gunduz M
N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15306675
[No Abstract] [Full Text] [Related]
33. [A phase II study of UFT in non-small cell lung cancer].
Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068
[TBL] [Abstract][Full Text] [Related]
34. [The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Yamashita K; Mitani K; Morishita Y; Inoue K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):767-73. PubMed ID: 2496666
[TBL] [Abstract][Full Text] [Related]
35. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
Suzuki M; Sekiguchi I; Tamada T; Nishida M
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
[TBL] [Abstract][Full Text] [Related]
36. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
37. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
[TBL] [Abstract][Full Text] [Related]
38. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
Shimoyama T; Shimizu T; Kusano H; Ishikawa H; Miyashita K; Nakazaki T; Yasutake T; Yoshida A; Yoshida K; Ogawa T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):125-30. PubMed ID: 8422176
[TBL] [Abstract][Full Text] [Related]
39. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
40. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
